Cargando…
Current treatments for non-small cell lung cancer
Despite improved methods of diagnosis and the development of different treatments, mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) accounts for the large majority of lung cancer cases. Therefore, it is important to review current methods of diagnosis and trea...
Autores principales: | Guo, Qianqian, Liu, Liwei, Chen, Zelong, Fan, Yannan, Zhou, Yang, Yuan, Ziqiao, Zhang, Wenzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403713/ https://www.ncbi.nlm.nih.gov/pubmed/36033435 http://dx.doi.org/10.3389/fonc.2022.945102 |
Ejemplares similares
-
The Role of Iron in Cancer Progression
por: Guo, Qianqian, et al.
Publicado: (2021) -
Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review
por: Sun, Qianqian, et al.
Publicado: (2022) -
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
por: Yan, Ningning, et al.
Publicado: (2022) -
Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
por: Melosky, Barbara
Publicado: (2017) -
Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects
por: Ryu, Rachel, et al.
Publicado: (2018)